Iterum Therapeutics Plc (ITRM) |
|
0.9 0.01 (1.12%)
|
08-13 15:54 |
|
Open: |
0.88 |
Pre. Close: |
0.89 |
|
High:
|
0.918 |
Low:
|
0.8751 |
|
Volume:
|
326,384 |
Market Cap:
|
19M |
|
|
|
|
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing anti-infectives for multi-drug resistant pathogens in Ireland and the United States. The company is developing sulopenem, a novel penem anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. Iterum Therapeutics plc was founded in 2015 and is headquartered in Dublin, Ireland. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.922 - 0.928 |
0.928 - 0.934 |
|
Low:
|
0.865 - 0.873 |
0.873 - 0.88 |
|
Close:
|
0.888 - 0.9 |
0.9 - 0.911 |
|
Technical analysis |
as of: 2020-08-13 4:35:31 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 1.26 One year: 1.42 |
| Support: |
Support1: 0.85 Support2: 0.71 |
| Resistance: |
Resistance1: 1.08 Resistance2: 1.22 |
| Pivot: |
1.03  |
| Moving Average: |
MA(5): 0.96 MA(20): 1.06
MA(100): 2.16 MA(250): 3.09 |
| MACD: |
MACD(12,26): -0.12 Signal(9): -0.13  |
| Stochastic oscillator: |
%K(14,3): 12.72 %D(3): 14.12 |
| RSI: |
RSI(14): 28.20 |
| 52-week: |
High: 7.24 Low: 0.85 Change(%): -86.7 |
| Average Vol(K): |
3-Month: 135541 10-Days: 36110 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.ITRM has closed above bottom band by 0.1%. Bollinger Bands are 79.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to ITRM's normal range. The bands have been in this narrow range for 38 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Tue, 11 Aug 2020
Iterum Therapeutics Commences Rights Offering Nasdaq:ITRM - GlobeNewswire
Mon, 10 Aug 2020
Iterum Therapeutics (ITRM) Receives a Hold from H.C. Wainwright - Smarter Analyst
Thu, 06 Aug 2020
Iterum Therapeutics Reports Second Quarter 2020 Financial Results - GlobeNewswire
Mon, 03 Aug 2020
Iterum Therapeutics plc (NASDAQ: ITRM) 52-Week High Located At $7.65, Forget The Dips, Just Ride The Rips - The Comet Reports
Wed, 22 Jul 2020
Iterum Therapeutics plc (ITRM) Sitting On The Launchpad, Waiting For The Long Term Buyers - Stocks Register
Wed, 22 Jul 2020
Iterum Therapeutics plc (NASDAQ:ITRM) share price rebounds 24.59% from the lows – but can it keep going? - Marketing Sentinel
|
Financial Analysis |
| Growth |
|
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NasdaqGM |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
18 |
| Shares Float (M) |
10 |
|
% Held by Insiders
|
3.58 |
|
% Held by Institutions
|
70.07 |
|
Shares Short (K)
|
385 |
|
Shares Short P. Month (K)
|
449 |
Stock Financials |
|
EPS
|
-6.728 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
-2.810 |
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-89.8 |
|
Return on Equity (ttm)
|
-1995.2 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
0.002 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-5.282 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-91 |
|
Levered Free Cash Flow (M)
|
-29 |
Stock Valuations |
|
PE Ratio
|
-0.13 |
|
PEG Ratio
|
|
|
Price to Book value
|
-0.32 |
|
Price to Sales
|
|
|
Price to Cash Flow
|
-0.18 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
